six
cell
line
cultur
develop
cellchip
use
prescreen
patient
sera
select
good
candid
cell
line
identif
membran
antigen
huvec
show
posit
bind
signal
patient
sera
confirm
presenc
aeca
bd
patient
howev
cell
also
abund
fluoresc
signal
suggest
cell
may
new
autoantibodi
target
fig
b
fluoresc
differ
fluoresc
stain
result
without
nucleu
among
six
cell
line
quantifi
use
imag
j
softwar
fig
intens
membran
stain
make
cell
line
good
candid
identif
membran
antigen
elisa
membran
antigen
serum
sampl
bd
patient
investig
select
subject
contain
larg
number
aeca
five
subject
bd
patient
present
rel
higher
optic
densiti
valu
select
analysi
fig
protein
immunoblot
perform
display
put
bind
target
detect
autoantibodi
bind
antigen
observ
igg
autoantibodi
cell
antigen
detect
bd
patient
bind
signal
detect
healthi
control
fig
newli
identifi
autoantigen
cut
polyacrylamid
gel
digest
trypsin
peptid
fragment
identifi
use
lcmalditoftof
mass
spectrometri
analyz
use
mascot
bioinformat
databas
obtain
amino
acid
sequenc
detect
protein
shown
target
protein
share
signific
sequenc
homolog
annexin
estim
molecular
weightpi
ncbi
access
number
mascot
score
match
uniqu
peptid
accur
determin
confid
interv
ci
indic
credibl
result
fig
select
target
protein
obtain
recombin
dna
technolog
sequenc
mass
spectrometri
use
western
blot
immunoprecipit
competit
immunofluoresc
confirm
protein
real
autoantigen
bd
success
first
express
purif
recombin
human
annexin
protein
perform
fig
b
purifi
annexin
protein
confirm
use
mass
spectrometri
fig
western
blot
purifi
mous
antihuman
annexin
monoclon
antibodi
success
data
shown
second
immunoprecipit
perform
determin
whether
detect
antigen
real
autoantigen
bd
shown
fig
band
annexin
clearli
present
immunoprecipit
indic
annexin
inde
autoantigen
bd
present
patient
blood
circul
furthermor
competit
immunofluoresc
assay
also
use
analyz
inhibitori
activ
annexin
protein
fig
shown
recombin
human
annexin
protein
could
significantli
reduc
bind
activ
bd
patient
sera
vitro
prove
antiannexin
antibodi
found
blood
circul
bd
patient
investig
role
annexin
correspond
antiannexin
elisa
develop
use
purifi
recombin
antigen
antiannexin
antibodi
detect
bd
patient
sle
patient
ss
patient
hc
reactiv
sera
igg
human
recombin
annexin
bd
patient
higher
sle
ss
appar
healthi
individu
p
fig
possibl
molecular
interact
annexin
process
bd
analyz
elisa
correlationship
annexin
fig
optic
densiti
obtain
sera
recombin
human
annexin
correl
recombin
human
bd
patient
p
sle
patient
p
immunohistochemistri
use
analyz
differ
protein
express
human
umbil
veinarteri
squamou
cell
lung
cancer
kidney
cancer
tissu
sampl
result
show
annexin
specif
express
human
umbil
veinarteri
vascular
endotheli
cell
cell
vessel
fig
b
high
express
annexin
clearli
observ
human
squamou
cell
lung
cancer
kidney
cancer
tissu
fig
result
consist
data
western
blot
analysi
also
show
express
annexin
cell
highest
among
cell
test
follow
cell
huvec
data
shown
stain
commerci
annexin
monoclon
antibodi
human
umbil
veinarteri
tissu
fig
consist
antiannexin
antibodyposit
bd
patient
sera
put
togeth
result
show
annexin
real
aeca
autoantigen
bd
correlationship
annexin
clinic
symptom
involv
bd
patient
analyz
among
bd
patient
subject
show
posit
reaction
recombin
human
annexin
protein
compar
clinic
inform
antiannexin
antibodyposit
neg
subject
vascular
involv
approxim
four
time
higher
antiannexin
antibodyposit
group
clinic
symptom
signific
differ
observ
detail
clinic
inform
bd
patient
analyz
summar
fig
primari
vascular
endotheli
cell
consid
origin
autoimmun
target
bd
cell
necessarili
best
candid
screen
blood
circul
autoantibodi
partli
due
cell
differenti
may
caus
variat
protein
abund
differ
studi
cellchip
design
identifi
autoantibodi
target
cell
found
cell
possess
signific
bind
abil
possibl
origin
fuse
cell
line
properti
huvec
annexin
phospholipidbind
protein
wide
distribut
throughout
cell
involv
sever
import
biolog
process
exocytosi
endocytosi
cell
cycl
regul
immunoglobulin
annexin
overexpress
describ
mani
cancer
includ
liver
lung
kidney
protein
might
play
import
role
tumor
cell
prolifer
regul
identifi
vascular
endotheli
cell
plasminogen
receptor
plasminogen
cell
surfac
annexin
also
play
pivot
role
process
thrombosi
antiphospholipid
syndrom
mediat
endotheli
cell
activ
glycoprotein
furthermor
deregul
annexin
express
acut
promyelocyt
leukemia
import
mechan
bleed
recent
studi
indic
annexin
may
target
autoantibodi
sle
ss
ra
system
vascul
hypothes
antiannexin
antibodi
induc
thrombosi
activ
endotheli
cell
inhibit
plasmin
furthermor
anoth
member
annexin
alreadi
describ
serum
antiannexin
v
antibodi
significantli
higher
neurobd
patient
compar
homolog
analysi
indic
amino
acid
sequenc
human
annexin
protein
ident
annexin
v
result
relat
reactiv
antiannexin
antibodi
sle
ss
consist
report
literatur
support
reliabl
studi
studi
annexin
suggest
novel
membran
autoantigen
bd
may
involv
process
capillari
injuri
bd
process
compar
clinic
inform
antiannexin
antibodyposit
neg
group
vascular
involv
four
time
higher
antiannexin
antibodyposit
group
indic
annexin
may
close
relationship
vascular
inflamm
damag
number
studi
shown
annexin
play
role
pathogen
research
believ
bd
relat
infect
microorgan
sometim
hsv
herp
simplex
viru
consid
involv
diseas
antihsv
antibodi
detect
circul
serum
bd
streptococcu
sangui
sangui
mainli
inhabit
mucou
membran
colon
mouth
throat
role
organ
bd
immunopathogenesi
sangui
detect
sera
bd
patient
highli
homolog
human
addit
demonstr
crossreact
antibodi
bd
patient
sera
sangui
recombin
peptid
also
elicit
immun
respons
human
respons
although
direct
primarili
microbi
provid
link
infect
pathogenesi
autoimmun
diseas
suggest
multipl
moreov
express
certain
cytokin
downregul
infect
bd
patient
exampl
inflammatori
factor
includ
upregul
downregul
patient
increas
level
also
observ
patient
bd
data
shown
summari
annexin
suggest
specif
vascular
endotheli
cell
membran
autoantigen
bd
howev
investig
necessari
elucid
exact
role
annexin
bd
pathogenesi
longterm
clinic
monitor
effect
annexin
patient
studi
serolog
criteria
evalu
assess
valid
cohort
subject
experiment
group
confirm
bd
patient
averag
age
year
rang
femal
male
patient
diseas
control
group
includ
sle
patient
averag
age
year
rang
femal
male
patient
ss
patient
averag
age
year
rang
femal
male
patient
healthi
control
group
appar
healthi
volunt
averag
age
year
rang
femal
male
diagnosi
bd
fulfil
criteria
propos
intern
studi
group
studi
approv
ethic
committe
chines
pla
gener
hospit
patient
gave
inform
consent
sampl
collect
sep
feb
dispens
store
test
human
tissu
assay
perform
beij
tiantan
hospit
method
studi
carri
accord
approv
guidelin
scientif
report
cell
line
use
studi
includ
human
umbil
vein
endotheli
cell
huvec
human
umbil
vein
cell
line
human
alveolar
epitheli
cell
line
human
embryon
kidney
cell
line
purchas
american
type
cultur
collect
manassa
va
human
immort
nontumorogen
keratinocyt
cell
line
hacat
suppli
cell
line
servic
eppelheim
germani
hacat
cultur
dmem
hyclon
ut
contain
fetal
bovin
serum
hyclon
ut
huvec
cultur
describ
oral
epitheli
cell
isol
healthi
donor
label
cpkq
accord
name
huvec
serv
control
origin
gener
vascular
epitheli
cell
huvec
cpkq
hacat
cell
serv
repres
organ
involv
cell
serv
repres
cancer
cell
line
multifunct
cellchip
construct
base
tradit
microarray
sampl
cultur
cell
place
cover
slip
fix
paraformaldehyd
cut
fragment
cover
slip
glu
microscop
slide
immunofluoresc
assay
carri
follow
sera
bd
patient
dilut
pb
incub
slide
h
extens
wash
slide
incub
fluorescein
isothiocyanateconjug
goatanti
human
igg
secondari
antibodi
immunohunt
beij
china
dilut
pb
h
slide
examin
fluoresc
microscopi
amg
bothel
wa
intens
obtain
use
imag
j
softwar
nih
md
display
intens
fluoresc
stain
result
without
nucleu
competit
immunofluoresc
assay
perform
cell
line
use
serum
antiannexin
antibodyposit
bd
patient
inhibit
assay
serum
preincub
annexin
protein
h
extens
wash
slide
incub
fluorescein
isothiocyanateconjug
goatanti
human
igg
secondari
antibodi
immunohunt
beij
china
dilut
pb
h
cell
membran
protein
extract
use
membran
extract
kit
sigma
mo
complet
proteas
inhibitor
cocktail
sigma
mo
extract
dispens
store
use
protein
use
coat
micropl
corn
ny
overnight
three
wash
pbst
plate
incub
goat
serum
h
sera
bd
patient
dilut
pb
ad
well
plate
incub
h
horseradishperoxidaseconjug
goat
antihuman
igg
invitrogen
ca
dilut
pb
dival
cation
incub
min
amount
bound
antibodi
quantifi
colorimetr
ad
tetramethylbenzidin
substrat
plate
read
spectrophotometr
nm
elisa
reader
tecan
hombrechtikon
switzerland
western
blot
perform
describ
slight
modif
cell
membran
protein
extract
use
membran
extract
kit
sigma
mo
complet
proteas
inhibitor
cocktail
sigma
mo
extract
dispens
store
use
cell
lysat
load
well
polyacrylamid
gel
separ
gel
transfer
onto
polyvinyliden
fluorid
membran
pvdf
merck
millipor
wash
twice
ultrapur
water
membran
block
nonfat
milk
pb
overnight
incub
bd
sera
select
due
rel
higher
optic
densiti
valu
dilut
sera
random
healthi
control
h
membran
extens
wash
four
time
pbst
buffer
remov
unbound
antibodi
final
incub
horseradishperoxidaseconjug
goat
antihuman
igg
immunohunt
beij
china
h
ecl
detect
carri
accord
product
instruct
applygen
beij
china
ingel
digest
mass
spectrometri
perform
describ
detail
briefli
excis
gel
piec
destain
mm
acetonitril
dri
vacuum
centrifug
mm
dithiotreitol
mm
ad
cover
gel
piec
sampl
reduc
h
cool
room
temperatur
dtt
solut
replac
roughli
volum
mm
iodoacetamid
mm
incub
min
room
temperatur
dark
gel
piec
wash
mm
acetonitril
min
liquid
phase
remov
gel
piec
complet
dri
vacuum
concentr
dri
gel
piec
cover
buffer
contain
trypsin
sigma
mo
digest
perform
overnight
excis
protein
band
identifi
use
proteom
analyz
lcmalditoftof
mass
spectromet
appli
biosystem
foster
citi
ca
mass
spectrometri
data
analyz
mascot
bioinformat
databas
search
engin
matrix
scienc
london
uk
procedur
protein
express
purif
perform
routin
brief
total
rna
isol
cell
use
trizol
reagent
invitrogen
ca
rtpcr
carri
accord
manufactur
instruct
fermenta
md
target
protein
overexpress
e
coli
follow
purif
recombin
protein
use
ninta
resin
qiagen
hilden
germani
concentr
protein
determin
use
bca
assay
kit
biosynthesi
biotechnolog
beij
china
purifi
recombin
protein
confirm
mass
spectrometri
western
blot
mous
antihuman
monoclon
antibodi
proteintech
chicago
il
immunoprecipit
perform
previous
put
autoantigen
incub
mix
sera
equal
volum
three
posit
bd
patient
western
blot
detect
overnight
thereaft
protein
asepharos
bead
sigma
mo
wash
pb
ad
mix
overnight
immunoprecipit
wash
three
time
pb
immunoprecipit
suspend
sampl
load
buffer
resolv
sdspage
elisa
human
recombin
protein
perform
describ
brief
recombin
human
annexin
sino
biolog
beij
china
use
coat
micropl
core
ny
overnight
three
wash
pbst
well
block
goat
serum
h
plate
incub
sera
patient
healthi
control
dilut
pb
h
three
wash
later
goat
antihuman
igghrp
immunohunt
beij
china
ad
well
plate
incub
addit
h
follow
three
wash
tetramethylbenzidin
tmb
citric
acid
g
hydroperitel
tmb
b
mm
citric
acid
mm
g
tmbl
ad
well
plate
incub
dark
room
temperatur
min
reaction
stop
ad
absorb
well
measur
plate
reader
nm
tecan
hombrechtikon
switzerland
immunohistochemistri
protocol
slight
modif
previous
human
umbil
veinarteri
squamou
cell
lung
cancer
kidney
cancer
tissu
sampl
treat
paraformaldehyd
overnight
fix
tissu
embed
paraffin
wax
fivemicrometerthick
paraffin
section
place
glass
slide
bake
min
incub
min
xylen
final
wash
pb
inhibit
endogen
peroxidas
section
first
incub
methanol
min
room
temperatur
section
boil
sodium
citratehydrochlor
acid
solut
min
incub
goat
serum
min
section
wash
pb
incub
overnight
mous
antihuman
annexin
monoclon
antibodi
proteintech
chicago
il
dilut
pb
section
wash
pb
remov
unbound
antibodi
incub
hrplabel
goat
antimous
igg
immunohunt
beij
china
section
wash
incub
dab
develop
peroxidas
activ
counterstain
perform
hematoxylin
section
dehydr
gradient
ethanol
approxim
min
concentr
place
xylen
min
observ
microscop
olympu
tokyo
japan
ttest
statist
spearman
correl
coeffici
fisher
exact
text
chisquar
test
analyz
use
spss
softwar
version
il
p
valu
less
consid
signific
critic
point
posit
definit
number
higher
valu
healthi
control
mean
sd
hwd
ypt
yqw
yzb
pc
design
research
pc
hy
ypx
ll
rb
hz
chi
sss
yjw
ybz
perform
experi
analyz
data
pc
cyz
xxw
hwd
gyc
wrote
manuscript
author
discuss
result
comment
manuscript
